|
|
Vol. 10.07 – 4 March, 2024
|
|
|
|
|
|
|
|
Scientists developed an innovative in vitro human three-dimensional (3D) normal skin model and a multicellular model of human cutaneous squamous cell carcinoma using 3D bioprinting technology. [Biofabrication]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
DERMAL STEM CELLS & TISSUE REGENERATION
|
|
|
|
|
|
Investigators generated OCT4 knockout clonal cell lines using immortalized human skin keratinocytes to identify a functional role for the protein.
[Cell Reports]
|
|
|
|
|
|
Through analysis of GEO datasets, scientists found elevated Gasdermin E (GSDME) levels in psoriatic lesional skin. Additionally, GSDME levels correlated with both psoriasis severity and response to biologics treatments. [Cell Death & Disease]
|
|
|
|
|
|
Treatment with cinnamic acid led to upregulation of oxytocin receptor and trichogenic gene expression in human dermal papilla cells.
[Scientific Reports]
|
|
|
|
|
|
|
|
Autophagy-dependent melanoma cells were compared with normal foreskin fibroblasts to elucidate the mechanism by which 1-phosphatidylinositol 3-phosphate 5-kinase (PIKFYVE) inhibition induced cell death. [Molecular Oncology]
|
|
|
|
|
|
Researchers established a daturataturin A (DTA) psoriasis-like keratinocytes model by stimulating HaCaT cells with M5 cocktail cytokines including interleukin (IL)-17A, IL-22, oncostatin M, IL-1α, and tumor necrosis factor-α, followed by intervention with DTA. [Biochemical Genetics]
|
|
|
|
|
|
|
|
The authors focus on the mechanisms regulating the initiation of cutaneous melanoma dormancy as well as those that are involved in the reawakening of dormant cutaneous melanoma cells. [Cancer Cell International]
|
|
|
|
|
|
|
|
A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center is now available for patients with advanced melanoma. It’s called TIL, short for tumor-infiltrating lymphocyte therapy. The one-time T-cell therapy infusion uses a patient’s own immune cells to fight their cancer. [Moffitt Cancer Center]
|
|
|
|
|
|
|
|
April 15 – 16, 2024 London, England, United Kingdom
|
|
|
|
|
|
|
|
|
|
|
University of Texas Southwestern Medical Center – Dallas, Texas, United States
|
|
|
|
|
|
|
Cyprus Cancer Research Institute – Aglandjia, Cyprus
|
|
|
|
|
|
|
UC Davis – Davis, California, United States
|
|
|
|
|
|
|
University of Michigan – Ann Arbor, Michigan, United States
|
|
|
|
|
|
|
Augusta University – Augusta, Georgia, United States
|
|
|
|
|
|